<DOC>
	<DOCNO>NCT01782118</DOCNO>
	<brief_summary>Background : Proton pump inhibitor ( PPI ) effective treat gastroesophageal reflux disease ( GERD ) . However , may associate increase risk gastrointestinal respiratory tract infection . Aim : To determine Lactobacillus GG ( LGG ) effective adjunct PPI reduce risk gastrointestinal respiratory tract infection child GERD . Study design : Randomized , double-blind , placebo control trial .</brief_summary>
	<brief_title>LGG Prevention Infectious Complications During PPI Treatment Children</brief_title>
	<detailed_description>Patients GERD treat PPI randomly assign receive LGG dose 10 ( 9 ) Colony Forming Units ( CFU ) twice daily 6 week comparable placebo twice daily 6 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>age &lt; 5 , clinical symptom GERD treatment proton pump inhibitor sign informed consent treatment PPI within last 4 week least 2 week administration probiotic within 7 day prior study acute chronic respiratory tract infection acute chronic gastrointestinal tract infection neurological disorder immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>